×

Substituted imidazoles useful in the treatment of inflammatory disease

  • US 5,965,583 A
  • Filed: 04/17/1998
  • Issued: 10/12/1999
  • Est. Priority Date: 04/24/1997
  • Status: Expired due to Term
First Claim
Patent Images

1. A compound of Formula I ##STR37## wherein:

  • R1 is phenyl, substituted phenyl where the substituents are selected from the group consisting of C1-5 alkyl, halogen, nitro, trifluoromethyl, and nitrile, or pyridinyl;

    R2 is phenyl, substituted phenyl where the substituents are selected from the group consisting of C1-5 alkyl, halogen, nitro, trifluoromethyl, and nitrile or pyridinyl where the pyridinyl is optionally C1-4 alkyl substituted;

    R3 is hydrogen, SEM, C1-5 alkoxycarbonyl, aryloxycarbonyl, arylC1-5 -alkyloxycarbonyl, arylC1-5 alkyl, substituted arylC1-5 alkyl where the aryl substituents are independently selected from one or more members of the group consisting of C1-5 alkyl, C1-5 alkoxy, halogen, amino, C1-5 alkylamino, and diC1-5 alkylamino, phthalimidoC1-5 -alkyl, aminoC1-5 alkyl, diaminoC1-5 alkyl, succinimidoC1-5 alkyl, C1-5 alkylcarbonyl, arylcarbonyl, C1-5 alkylcarbonylC1-5 alkyl, aryloxycarbonylC1-5 alkyl;

    R4 is (A)--(CH2)q --X where;

    A is vinylene, ethynylene or ##STR38## where R5 is selected from the group consisting of hydrogen, C1-5 alkyl, phenyl and phenylC1-5 alkyl;

    q is 0-9;

    X is selected from the group consisting of hydrogen, hydroxy, vinyl, substituted vinyl where one or more substituents are selected from the group consisting of fluorine, bromine, chlorine and iodine), ethynyl, substituted ethynyl (where the substituents are selected from one or more of the group consisting of fluorine, bromine chlorine and iodine, C1-5 alkyl, substituted C1-5 alkyl where the alkyl substituents are selected from the group consisting of one or more C1-5 alkoxy trihaloalkyl, phthalimido and amino, C3-7 cycloalkyl, C1-5 alkoxy, substituted C1-5 alkoxy where the alkyl substituents are selected from the group consisting of phthalimido and amino, phthalimidooxy, phenoxy, substituted phenoxy (where the phenyl substituents are selected from the group consisting of C1-5 alkyl, halogen and C1-5 alkoxy), phenyl, substituted phenyl where the phenyl substituents are selected from the group consisting of C1-5 alkyl, halogen and C1-5 alkoxy, arylC1-5 alkyl, substituted arylC1-5 alkyl where the aryl substituents are selected from the group consisting of C1-5 alkyl, halogen and C1-5 alkoxy, arylhydroxyC1-5 alkyl amino, C1-5 alkylamino, diC1-5 alkylamino, nitrile, oxime, benxyloxyimino, C1-5 alkyloxyimino, phthalimido, succinimido, C1-5 alkylcarbonyloxy, phenylcarbonyloxy, substituted phenylcarbonyloxy where the phenyl substitutents are selected from the group consisting of C1-5 alkyl, halogen and C1-5 alkoxy, phenylC1-5 alkylcarbonyloxy, where the phenyl substitutents are selected from the group consisting of C1-5 alkyl, halogen and C1-5 alkoxy, aminocarbonyloxy, C1-5 alkylaminocarbonyloxy, diC1-5 alkylaminocarbonyloxy, C1-5 alkoxycarbonyloxy, substituted C1-5 alkoxycarbonyloxy where the alkyl substituents are selected from the group consisting of methyl, ethyl, isopropyl and hexyl, phenoxycarbonyloxy, substituted phenoxycarbonyloxy where the phenyl substituents are selected from the group consisting of C1-5 alkyl, C1-5 alkoxy, and halogen, C1-5 alkylthio, substituted C1-5 alkylthio where the alkyl substituents are selected from the group consisting of hydroxy and phthalimido, C1-5 alkylsulfonyl, phenylsulfonyl, substituted phenylsulfonyl where the phenyl substituents are selected from the group consisting of bromine, fluorine, chloride, C1-5 alkoxy and trifluoromethyl;

    with the proviso;

    if A is ##STR39## q is 0 and X is H, R3 may not be SEM; and

    pharmaceutically acceptable salts thereof.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×